FDA
-
-
-
-
-
-
-
Protalix BioTherapeutics to Announce Fiscal Year 2025 Financial Results and Business Update on March 18, 2026
-
-
-
-
-
-
-
Protalix Biotherapeutics and Secarna Pharmaceuticals Enter into Collaboration and Option Agreement
-
-
-
-
-
-
-
Protalix BioTherapeutics to Present at the H.C. Wainwright 27th Annual Global Investment Conference
-
-
-
-
-
-
-
Protalix BioTherapeutics to Present at the 3rd Annual H.C. Wainwright BioConnect Investor Conference at Nasdaq NYC
-
-
-
-
-
-
-
Protalix BioTherapeutics (PLX) Issues 2025 Letter to Stockholders
-
-
-
-
-
-
-
Protalix BioTherapeutics to Present at the H.C. Wainwright 26th Annual Global Investment Conference
-
-
-
-
-
-
-
Protalix BioTherapeutics Reports First Quarter 2024 Financial and Business Results
-
335,733 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


